-
Something wrong with this record ?
Polymorphisms of TGF-beta1 in cystic fibrosis patients
J Brazova, K Sismova, V Vavrova, J Bartosova, M Jr Macek, H Lauschman, A Sediva
Language English Country United States
Document type Research Support, Non-U.S. Gov't
Grant support
NR8458
MZ0
CEP Register
NI7486
MZ0
CEP Register
NR7974
MZ0
CEP Register
Digital library NLK
Full text - Část
Full text - Část
Source
Source
NLK
ScienceDirect (archiv)
from 1999-01-01 to 2009-12-31
- MeSH
- Cystic Fibrosis epidemiology genetics metabolism pathology MeSH
- Child MeSH
- Adult MeSH
- Phenotype MeSH
- Genotype MeSH
- Infant MeSH
- Humans MeSH
- Adolescent MeSH
- Polymorphism, Genetic * genetics MeSH
- Child, Preschool MeSH
- Transforming Growth Factor beta1 * genetics metabolism MeSH
- Check Tag
- Child MeSH
- Adult MeSH
- Infant MeSH
- Humans MeSH
- Adolescent MeSH
- Male MeSH
- Child, Preschool MeSH
- Female MeSH
- Publication type
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Czech Republic MeSH
There is a significant phenotypic variance among cystic fibrosis (CF) patients. Due to the role of TGF-beta1 in fibrotic processes we investigated its role in CF pathogenesis. TGF-beta 1 codons 10 and 25 were genotyped in 118 Czech CF patients and 268 controls by PCR-ARMS. Difference between CF and controls was found at codon 10, lower frequency of T/T homozygotes, and codon 25, higher frequency of G/C heterozygotes. We did not prove the association of TGF-beta1 polymorphisms and lung function in CF, however, the TT (codon 10)/GG (codon 25) genotype was preferentially associated with CF-related liver disease and diabetes. Independent of the TGF-beta1 genotype, production of cytokine was higher in patients than in controls with the notable exception of very low levels in Burkholderia cepacia complex colonized patients. In CF, both extremes, highest or lowest TGF-beta 1 production, were associated with impaired lung function.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13009622
- 003
- CZ-PrNML
- 005
- 20130729074728.0
- 007
- ta
- 008
- 130312s2006 xxud f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.clim.2006.08.015 $2 doi
- 035 __
- $a (PubMed)17052957
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Brázová, Jitka $7 xx0082231 $u Institute of Immunology, University Hospital Motol, Charles University, Prague, V Uvalu 84, 150 06 Prague 5, Czech Republic
- 245 10
- $a Polymorphisms of TGF-beta1 in cystic fibrosis patients / $c J Brazova, K Sismova, V Vavrova, J Bartosova, M Jr Macek, H Lauschman, A Sediva
- 520 9_
- $a There is a significant phenotypic variance among cystic fibrosis (CF) patients. Due to the role of TGF-beta1 in fibrotic processes we investigated its role in CF pathogenesis. TGF-beta 1 codons 10 and 25 were genotyped in 118 Czech CF patients and 268 controls by PCR-ARMS. Difference between CF and controls was found at codon 10, lower frequency of T/T homozygotes, and codon 25, higher frequency of G/C heterozygotes. We did not prove the association of TGF-beta1 polymorphisms and lung function in CF, however, the TT (codon 10)/GG (codon 25) genotype was preferentially associated with CF-related liver disease and diabetes. Independent of the TGF-beta1 genotype, production of cytokine was higher in patients than in controls with the notable exception of very low levels in Burkholderia cepacia complex colonized patients. In CF, both extremes, highest or lowest TGF-beta 1 production, were associated with impaired lung function.
- 590 __
- $a bohemika - dle Pubmed
- 650 02
- $a mladiství $7 D000293
- 650 02
- $a dospělí $7 D000328
- 650 02
- $a dítě $7 D002648
- 650 02
- $a předškolní dítě $7 D002675
- 650 02
- $a cystická fibróza $x epidemiologie $x genetika $x metabolismus $x patologie $7 D003550
- 650 02
- $a ženské pohlaví $7 D005260
- 650 02
- $a genotyp $7 D005838
- 650 02
- $a lidé $7 D006801
- 650 02
- $a kojenec $7 D007223
- 650 02
- $a mužské pohlaví $7 D008297
- 650 02
- $a fenotyp $7 D010641
- 650 12
- $a polymorfismus genetický $x genetika $7 D011110
- 650 12
- $a transformující růstový faktor beta1 $x genetika $x metabolismus $7 D053773
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Šišmová, Kristýna. $7 xx0222723 $u Institute of Immunology, University Hospital Motol, Charles University, Prague, V Uvalu 84, 150 06 Prague 5, Czech Republic
- 700 1_
- $a Vávrová, Věra, $d 1928- $7 nlk19990074045 $u Paediatric Department, University Hospital Motol, Charles University, Prague, Czech Republic
- 700 1_
- $a Bartošová, Jana $7 xx0082230 $u Paediatric Department, University Hospital Motol, Charles University, Prague, Czech Republic
- 700 1_
- $a Macek, Milan, $d 1961- $7 mzk2006348713 $u Institute of Biology and Medical Genetics, University Hospital Motol, Charles University, Prague, Czech Republic
- 700 1_
- $a Lauschmann, Hynek. $7 _AN048571 $u Faculty of Nuclear Sciences and Physical Engineering, Czech Technical University, Prague, Czech Republic
- 700 1_
- $a Šedivá, Anna, $d 1955- $7 xx0000191 $u Institute of Immunology, University Hospital Motol, Charles University, Prague, V Uvalu 84, 150 06 Prague 5, Czech Republic
- 773 0_
- $t Clinical Immunology $x 1521-6616 $g Roč. 121, č. 3 (2006), s. 350-357 $p Clin Immunol $w MED00005218
- 773 0_
- $p Clin Immunol $g 121(3):350-357, 2006 Dec $x 1521-6616
- 910 __
- $a ABA008 $b B 1440 $y 3 $z 0
- 990 __
- $a 20130312142438 $b ABA008
- 991 __
- $a 20130729075222 $b ABA008
- 999 __
- $a ok $b bmc $g 972445 $s 807881
- BAS __
- $a 3
- BMC __
- $x MED00005218 $i 1521-6616 $a 2006 $b 121 $c 3 $d 350-357 $m Clinical immunology $n Clin Immunol
- GRA __
- $a NR8458 $p MZ0
- GRA __
- $a NI7486 $p MZ0
- GRA __
- $a NR7974 $p MZ0
- LZP __
- $c NLK115 $d 20130313 $a 2013-03/gvlm